Santhera Pharmaceuticals (0QN1.LSE) Q2 2026 Earnings

Apr 28Confirmed
Q3 2024
Q2 2025
Q3 2025
Q2 2026
-3.03
-2.28
-1.54
-0.79

Details

Expected EPS
N/A
Actual EPS
-0.7862631641200001
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Santhera Pharmaceuticals⁩ (⁦0QN1.LSE⁩) has reported earnings of ⁦-0.7862631641200001⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts